Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
No Fixed Assets in the last few periods;
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024
Compare Balance Sheet Results of Kabra Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
23.71
6.27
17.44
278.15%
Share Warrants & Outstandings
Total Reserve
0.95
4.76
-3.81
-80.04%
Shareholder's Funds
24.65
11.04
13.61
123.28%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
2.26
-2.26
-100.00%
Secured Loans
0.00
0.80
-0.80
-100.00%
Unsecured Loans
0.00
1.45
-1.45
-100.00%
Deferred Tax Assets / Liabilities
0.00
-0.02
0.02
100.00%
Other Long Term Liabilities
0.00
0.16
-0.16
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
2.39
-2.39
-100.00%
Current Liabilities
Trade Payables
0.00
5.97
-5.97
-100.00%
Other Current Liabilities
0.14
3.70
-3.56
-96.22%
Short Term Borrowings
0.44
5.00
-4.56
-91.20%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
0.57
14.67
-14.10
-96.11%
Total Liabilities
25.23
28.10
-2.87
-10.21%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.05
1.10
-1.05
-95.45%
Less: Accumulated Depreciation
0.01
0.14
-0.13
-92.86%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
0.96
-0.92
-95.83%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
0.02
0.00
0.02
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.07
0.96
-0.89
-92.71%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.00
0.72
-0.72
-100.00%
Sundry Debtors
0.60
24.55
-23.95
-97.56%
Cash and Bank
21.30
0.20
21.10
10,550.00%
Other Current Assets
0.00
0.14
-0.14
-100.00%
Short Term Loans and Advances
3.26
1.55
1.71
110.32%
Total Current Assets
25.16
27.15
-1.99
-7.33%
Net Current Assets (Including Current Investments)
24.59
12.47
12.12
97.19%
Total Current Assets Excluding Current Investments
25.16
27.15
-1.99
-7.33%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
25.23
28.10
-2.87
-10.21%
Contingent Liabilities
0.49
0.00
0.49
0.00%
Total Debt
0.44
7.26
-6.82
-93.94%
Book Value per share (adjusted)
10.40
17.60
-7.20
-40.91%
Annual - Borrowings
Borrowings 0.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -74.27% vs 23.91% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
No Fixed Assets in the last few periods;
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 25.16 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 452.97% vs 569.12% in Mar 2024






